Short Interest in Siemens Healthineers AG (OTCMKTS:SMMNY) Rises By 143.6%

Siemens Healthineers AG (OTCMKTS:SMMNY) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totaling 125,563 shares, a growth of 143.6% from the June 30th total of 51,538 shares. Based on an average trading volume of 209,024 shares, the short-interest ratio is presently 0.6 days.

Analysts Set New Price Targets

Separately, Zacks Research lowered shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

SMMNY opened at $21.44 on Thursday. The business has a fifty day moving average of $19.91 and a 200 day moving average of $21.86. Siemens Healthineers has a 52-week low of $19.20 and a 52-week high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY) last released its earnings results on Thursday, May 7th. The company reported $0.31 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.